Tumor markers produced by cancer cells or normal cells in response to cancer such as prostate-specific antigen (PSA) for prostate cancer or carcinoembryonic antigen (CEA) for colorectal cancer can indicate the presence of metastasis or monitor treatment response (108). Here, CEACAM5 is linked to colorectal cancer.